In our study, JX-594 effectively remodeled the TME both in the primary tumors (Figure 4) and distant lung metastatic sites (Figure 5) through the activation of the immune system, which increased the tumor-infiltrating CD4/8+ T cells and DCs. Here, CD4 is linked to neoplasm.